leupeptin (Millipore)
Name:
Leupeptin
Description:
Catalog Number:
l8511
Price:
None
|
Buy from Supplier |
Structured Review

https://www.bioz.com/result/leupeptin/product/Millipore
Average 99 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
1) Product Images from "Protein instability, haploinsufficiency, and cortical hyper-excitability underlie STXBP1 encephalopathy"
Article Title: Protein instability, haploinsufficiency, and cortical hyper-excitability underlie STXBP1 encephalopathy
Journal: Brain
doi: 10.1093/brain/awy046

Figure Legend Snippet: Cellular stability of wild-type and human disease variants of Munc18-1 in HEK293 cells and neurons. ( A ) Immunochemistry of HEK293 cells infected with wild-type Munc18-1 (WT), C180Y, M443R, C522R and T574P constructs stained for Munc18-1, EGFP and Golgi marker (GM130). ( B ) Normalized Munc18-1 levels in HEK293 cells after viral infection with wild-type, C180Y, M443R, C522R and T574P constructs. The inset shows representative western blot of HEK293 cells after viral infection; n = 5, 5, 5, 2 and 2, respectively. ( C ) Western blot analysis of Munc18-1 protein levels 0, 6, 12, 24 and 30 h after block of protein synthesis with cycloheximide for HEK293 cells infected with wild-type, C180Y, M433R, C522R or T574P constructs. The infection with wild-type construct was used as a control for all performed western blot analysis. ( D ) Quantitative analysis of the Munc18-1 protein expression from western blots in HEK cells represented in C . ( E ) Western blot analysis of Munc18-1 protein levels 0, 12, 24 and 36 h after block of protein synthesis with cycloheximide for wild-type, C180Y, M433R, C522R or T574P constructs in Stxbp1 null neurons. The infection with wild-type construct was used as a control for all performed western blot analysis. ( F ) Quantitative analysis of the Munc18-1 protein expression from western blots in neurons represented in E . ( G–I ) Normalized Munc18-1 protein levels from three constructs expressed in HEK cells treated with MG132, Leupeptin or Pepstatin; n = 3, 2 and 2, respectively.
Techniques Used: Infection, Construct, Staining, Marker, Western Blot, Blocking Assay, Expressing
2) Product Images from "Autophagy-Lysosome Pathway in Renal Tubular Epithelial Cells Is Disrupted by Advanced Glycation End Products in Diabetic Nephropathy *"
Article Title: Autophagy-Lysosome Pathway in Renal Tubular Epithelial Cells Is Disrupted by Advanced Glycation End Products in Diabetic Nephropathy *
Journal: The Journal of Biological Chemistry
doi: 10.1074/jbc.M115.666354

Figure Legend Snippet: Autophagosome and lysosome fusion analysis and LC3 turnover assay in vitro . A , Western blot analysis of LC3 and the difference in the LC3-II levels between samples with and without bafilomycin A1 ( Baf A1 ), leupeptin ( LEU ), and chloroquine ( CQ ) was compared
Techniques Used: LC3 Turnover Assay, In Vitro, Western Blot
3) Product Images from "Ii Chain Controls the Transport of Major Histocompatibility Complex Class II Molecules to and from Lysosomes"
Article Title: Ii Chain Controls the Transport of Major Histocompatibility Complex Class II Molecules to and from Lysosomes
Journal: The Journal of Cell Biology
doi:
![... synthesized MHC class II molecules to lysosomes in leupeptin-treated cells analyzed by Percoll gradient centrifugation. ( A ... Selective redistribution of newly synthesized MHC class II molecules to lysosomes in leupeptin-treated cells analyzed by Percoll gradient centrifugation. ( A ) Leupeptin does not affect the density of compartments containing β-hexosaminidase and Tfn-HRP, markers of lysosomes and endosomes, respectively. After a 3-h incubation with or without 2 mM leupeptin, cells were permitted to internalize Tfn coupled to HRP for 30 min at 37°C (in the presence or absence of leupeptin) before homogenization and fractionation on Percoll density gradients. The β-hexosaminidase and HRP activities were determined in individual fractions. High density fractions (bottom of the gradient) contained most of the β-hexosaminidase activity, while Tfn-HRP was mainly present in low density fractions. No difference was observed between leupeptin-treated and control cells. ( B ) Redistribution of newly synthesized MHC class II molecules into high density fractions in leupeptin-treated cells. After a pulse of [ 35 S]methionine and a 1-, 2-, or 4-h chase in the absence ( left ) or presence ( right ) of leupeptin, I-A b –expressing A20 cells were fractionated on Percoll gradients. The membranes in each of the gradient fractions were pelleted by centrifugation, lysed in Triton X-100, and then immunoprecipitated using mAbs to I-A b (Y3P). The samples were analyzed by SDS-PAGE, and bands corresponding to class II β chains were quantified by phosphorimaging and optical densitometry. Ii-p10 intensity was also quantified after the 4-h chase in the presence of leupeptin ( bottom left ). Leupeptin caused a strong redistribution of class II into high density fractions. The majority of Ii-p10 was also found in lysosome-containing fractions. As expected, Ii-p10 was barely detectable in control cells and thus was not shown.](https://storage.googleapis.com/bioz_article_images/PMC2139866/JCB.brachet5b1.jpg)
Figure Legend Snippet: Selective redistribution of newly synthesized MHC class II molecules to lysosomes in leupeptin-treated cells analyzed by Percoll gradient centrifugation. ( A ) Leupeptin does not affect the density of compartments containing β-hexosaminidase and Tfn-HRP, markers of lysosomes and endosomes, respectively. After a 3-h incubation with or without 2 mM leupeptin, cells were permitted to internalize Tfn coupled to HRP for 30 min at 37°C (in the presence or absence of leupeptin) before homogenization and fractionation on Percoll density gradients. The β-hexosaminidase and HRP activities were determined in individual fractions. High density fractions (bottom of the gradient) contained most of the β-hexosaminidase activity, while Tfn-HRP was mainly present in low density fractions. No difference was observed between leupeptin-treated and control cells. ( B ) Redistribution of newly synthesized MHC class II molecules into high density fractions in leupeptin-treated cells. After a pulse of [ 35 S]methionine and a 1-, 2-, or 4-h chase in the absence ( left ) or presence ( right ) of leupeptin, I-A b –expressing A20 cells were fractionated on Percoll gradients. The membranes in each of the gradient fractions were pelleted by centrifugation, lysed in Triton X-100, and then immunoprecipitated using mAbs to I-A b (Y3P). The samples were analyzed by SDS-PAGE, and bands corresponding to class II β chains were quantified by phosphorimaging and optical densitometry. Ii-p10 intensity was also quantified after the 4-h chase in the presence of leupeptin ( bottom left ). Leupeptin caused a strong redistribution of class II into high density fractions. The majority of Ii-p10 was also found in lysosome-containing fractions. As expected, Ii-p10 was barely detectable in control cells and thus was not shown.
Techniques Used: Synthesized, Gradient Centrifugation, Incubation, Homogenization, Fractionation, Activity Assay, Expressing, Centrifugation, Immunoprecipitation, SDS Page

Figure Legend Snippet: Reversal of the leupeptin block results in MHC class II transport from lysosomes to the cell surface. ( A ) Reversibility of the effect of leupeptin on the intracellular retention of I-A b class II molecules. Cells were metabolically labeled for 20 min, and then chased in the continous presence of leupeptin for 4 h. Leupeptin was then removed, and the cells were incubated for 0–24 h. After cell surface biotinylation, the cells were lysed, and total ( left ) or surface ( right ) I-A b molecules were immunoprecipitated sequentially. Upon removal of leupeptin, the total amount of p70 (the Ii-p10–αβ complex) slowly decreased, while the amount of peptide-loaded, SDS-stable compact dimers (“ C ”) increased. Ii-p10 completely disappeared over this time course. After a lag (see B ), compact dimers began to appear at the cell surface. ( B ) Kinetics of compact dimer formation and transport to the cell surface. Bands corresponding to total and surface compact dimers were quantified by phosphorimaging. The lag between formation of compact dimers and their subsequent appearance at the cell surface was 3–4 h.
Techniques Used: Blocking Assay, Metabolic Labelling, Labeling, Incubation, Immunoprecipitation

Figure Legend Snippet: Distribution of MHC class II, Ii chain, and lgp-B in leupeptin-treated cells. ( A ) Quantification of MHC class II, Ii, and lgp-B in control and leupeptin-treated cells. The quantifications were carried out on ultrathin cryosections immunogold labeled for Ii chain (anti–Ii cytosolic tail mAb IN1) and MHC class II (rabbit anti–I-A cytoplasmic domain serum) or immunogold labeled for lgp-B (mAb GL2A7) and MHC class II (rabbit anti–I-A cytoplasmic domain serum) or immunogold labeled for lgp-B (mAb GL2A7) and MHC class II (rabbit anti–I-A cytoplasmic domain serum). In each case, 40 cell profiles were analyzed. ( B ) Immunogold localization of Ii chain, lgp-B, and I-A in leupeptin-treated cells. ( Upper panel ) Ultrathin cryosections were double immunogold labeled with the Ii chain antibody IN-1 (anti–Ii cytosolic domain; Ii CYT ) and rabbit anti–I-A cytosolic tail polyclonal antibody. Ii chain accumulates in I-A–positive compartments displaying internal vesicles and electron-dense content. ( Lower panel ) Ultrathin cryosections were double immunogold labeled with the anti–lgp-B mAb GL2A7 and rabbit anti–I-A cytosolic tail polyclonal antibody. Class II molecules were visualized in electron-dense, lgp-B–positive compartments. The size of the gold particles is indicated. Bars, 120 nm.
Techniques Used: Labeling

Figure Legend Snippet: Intracellular retention of Ii-p10–associated class II molecules. Cells were pulsed for 20 min and chased for the indicated times (h) in the presence or absence of 2 mM leupeptin. At each time point, the cells were surface biotinylated before lysis. Total and cell surface biotinylated class II molecules were sequentially immunoprecipitated using the mAb Y3P and streptavidin-agarose. The samples were then analyzed by SDS-PAGE without boiling before electrophoresis. In untreated control cells ( top ), peptideloaded, 60-kD compact αβ dimers (“ C ”) began to appear both in total lysates and on the surface after 0.5 h of chase. A small amount of the p70 complex of Ii-p10–αβ dimers appeared transiently, beginning also at 0.5 h of chase. In leupeptin-treated cells ( bottom ), p70 began to accumulate in total lysates by 0.5 h, but little was recovered at the plasma membrane. Peptide-loaded compact dimers only began to appear after 2–4 h of chase both in lysates and at the cell surface.
Techniques Used: Lysis, Immunoprecipitation, SDS Page, Electrophoresis

Figure Legend Snippet: Fractionation of leupeptin-treated A20 cells by free flow electrophoresis. ( A ) A20 cells were pulse labeled for 20 min and chased for 2 h in the presence of leupeptin before fractionation by FFE. Membranes collected in each fraction were pelleted by centrifugation and lysed in Triton X-100, and I-A b class II molecules were immunoprecipitated using mAb MKD6. The samples were then analyzed by SDS-PAGE without boiling. The positions of compact dimers (“ C ”), α, β chains, Ii-p10, and a p12 protein of unknown origin are indicated relative to the positions of markers for the major protein peak (plasma membrane), endosomes/lysosomes (β-hexosaminidase), and anodally shifted CIIVcontaining fractions. ( Left ) Anode; ( right ) cathode. ( B ) I-A b – expressing A20 cells were pulse labeled for 20 min and chased for 4 h in the presence of leupeptin before fractionation by FFE. The positions of p70 (Ii-p10–αβ complexes), 60-kD peptide-loaded compact dimers, free α and β chains, and Ii-p10 are indicated. ( C ) Positions of marker enzymes for plasma membrane (alkaline phosphodiesterase) and endosomes/lysosomes (β-hexosaminidase) in the FFE profile shown in B. p70 codistributed largely with the lysosomal marker β-hexosaminidase.
Techniques Used: Fractionation, Flow Cytometry, Electrophoresis, Labeling, Centrifugation, Immunoprecipitation, SDS Page, Expressing, Marker

Figure Legend Snippet: Leupeptin treatment causes MHC class II molecules to accumulate in lgp-containing structures by immunofluorescence microscopy. Control or leupeptintreated (3 h, 2 mM leupeptin) I-A b –expressing A20 cells were fixed, permeabilized, and then stained for MHC class II (FITC, using mAb Y3P, two upper panels ) vs lgp-B (TRITC, using mAb GL2A7, lower two panels ). In control cells, the small amount of intracellular MHC class II was localized to structures that were generally negative for lgp-B. These probably represented CIIVs a nd early endosomes. Leupeptin treatment, however, induced extensive colocalization of class II and lgp-B.
Techniques Used: Immunofluorescence, Microscopy, Expressing, Staining

Figure Legend Snippet: Immunogold localization of MHC class II molecules in leupeptin-treated cells. Ultrathin cryosections were immunogold labeled with the anti–class II mAb M5.114 and protein A–gold (PAG-10). ( A ) In control cells, MHC class II molecules are found on the plasma membrane, in intracellular compartments characterized by the presence of internal membranes. ( B ) In leupeptin-treated cells (18-h treatment), MHC class II molecules were detected on the plasma membrane and accumulate in electron-dense compartments displaying internal membranes. Bars, 120 nm.
Techniques Used: Labeling
![Leupeptin induces an accumulation of SDS- resistant I-A b ... Leupeptin induces an accumulation of SDS- resistant I-A b Ii-p10 complexes. ( A ) Leupeptin induces the accumulation of 10-kD (Ii-p10) and 70-kD (p70) proteins that coprecipitate with I-A b . I-A b –expressing A20 cells were pulsed for 20 min with [ 35 S]methionine and chased at 37°C for the indicated times in the presence or absence of 2 mM leupeptin. After lysis, the I-A b molecules were immunoprecipitated using the Y3P mAb. The samples were not boiled before SDS-PAGE. Labeled class II molecules were not detected before 30 min of chase because the Y3P mAb used for immunoprecipitation does not detect immature αβ dimers complexed with intact Ii chain. ( B ) p70 represents SDS-stable complexes containing class II α and β chains and a 10-kD protein. After a 20-min pulse and 4-h chase with or without 2 mM leupeptin (lanes Lp and C , respectively), class II molecules were immunoprecipitated using the Y3P mAb, and the samples were boiled ( B ) or not boiled ( NB ) before SDSPAGE. After boiling, p70 dissociated quantitatively into monomers corresponding to αβ and Ii-p10. ( C ) p70 represents SDS-stable I-A b αβ–Ii-p10 complexes. After a 20-min pulse and 4-h chase in the presence of leupeptin, class II molecules were immunoprecipitated with either anti–I-A b (Y3P) or anti–Ii chain cytoplasmic domain (IN-1) mAbs. While both antibodies precipitated the p70 complex, only anti–class II mAb precipitated the 60-kD SDS-stable compact dimer. Thus, p70 but not compact dimers are complexed with Ii chain or Ii chain fragments (i.e., Ii-p10) that contain the Ii chain cytoplasmic domain. ( D ) Kinetics of association between Ii-p10 and I-A b or I-A d . Pulse-chase experiments were performed as above using A20 cells expressing only I-A d or expressing both I-A d and I-A b . I-A d or I-A b –containing complexes were then immunoprecipitated using specific mAbs (Y3P and MKD6, respectively), and the amounts of Ii-p10 associated to the class II molecules were quantified by phosphorimaging. The association of Ii-p10 with I-A b persisted throughout the chase period, while Ii-p10–I-A d complexes appeared only transiently.](https://storage.googleapis.com/bioz_article_images/PMC2139866/JCB.brachet1d.jpg)
Figure Legend Snippet: Leupeptin induces an accumulation of SDS- resistant I-A b Ii-p10 complexes. ( A ) Leupeptin induces the accumulation of 10-kD (Ii-p10) and 70-kD (p70) proteins that coprecipitate with I-A b . I-A b –expressing A20 cells were pulsed for 20 min with [ 35 S]methionine and chased at 37°C for the indicated times in the presence or absence of 2 mM leupeptin. After lysis, the I-A b molecules were immunoprecipitated using the Y3P mAb. The samples were not boiled before SDS-PAGE. Labeled class II molecules were not detected before 30 min of chase because the Y3P mAb used for immunoprecipitation does not detect immature αβ dimers complexed with intact Ii chain. ( B ) p70 represents SDS-stable complexes containing class II α and β chains and a 10-kD protein. After a 20-min pulse and 4-h chase with or without 2 mM leupeptin (lanes Lp and C , respectively), class II molecules were immunoprecipitated using the Y3P mAb, and the samples were boiled ( B ) or not boiled ( NB ) before SDSPAGE. After boiling, p70 dissociated quantitatively into monomers corresponding to αβ and Ii-p10. ( C ) p70 represents SDS-stable I-A b αβ–Ii-p10 complexes. After a 20-min pulse and 4-h chase in the presence of leupeptin, class II molecules were immunoprecipitated with either anti–I-A b (Y3P) or anti–Ii chain cytoplasmic domain (IN-1) mAbs. While both antibodies precipitated the p70 complex, only anti–class II mAb precipitated the 60-kD SDS-stable compact dimer. Thus, p70 but not compact dimers are complexed with Ii chain or Ii chain fragments (i.e., Ii-p10) that contain the Ii chain cytoplasmic domain. ( D ) Kinetics of association between Ii-p10 and I-A b or I-A d . Pulse-chase experiments were performed as above using A20 cells expressing only I-A d or expressing both I-A d and I-A b . I-A d or I-A b –containing complexes were then immunoprecipitated using specific mAbs (Y3P and MKD6, respectively), and the amounts of Ii-p10 associated to the class II molecules were quantified by phosphorimaging. The association of Ii-p10 with I-A b persisted throughout the chase period, while Ii-p10–I-A d complexes appeared only transiently.
Techniques Used: Expressing, Lysis, Immunoprecipitation, SDS Page, Labeling, Pulse Chase
4) Product Images from "Beclin-1 regulates cigarette smoke–induced kidney injury in a murine model of chronic obstructive pulmonary disease"
Article Title: Beclin-1 regulates cigarette smoke–induced kidney injury in a murine model of chronic obstructive pulmonary disease
Journal: JCI Insight
doi: 10.1172/jci.insight.99592

Figure Legend Snippet: Autophagy activity is induced in mouse kidneys after cigarette smoke exposure. ( A ) Scheme representing autophagic flux experiment in which leupeptin or bafilomycin A1 inhibits autophagosome degradation, leading to autophagosome accumulation. ( B ) Mice subjected to RA or CS for 2 months (left panel) or 6 months (right panel) were assayed for autophagic flux in vivo by injection with leupeptin or vehicle (PBS), followed by Western blotting for LC3B expression in kidney tissue after 2 and 6 months of exposure and Beclin-1 expression after 6 months of exposure. Dot plots represent quantitation of Western blots ( n = 3 per group, except for 6 months CS + leupeptin exposure, n = 2 per group). ( C ) HK-2 cells were exposed to CSE in the absence or presence of bafilomycin A1. Representative Western blot of Beclin-1 and LC3B expression to determine autophagic flux in vitro. Dot plots represent quantitation of 3 independent experiments. All data are mean ± SEM.* P
Techniques Used: Activity Assay, Mouse Assay, In Vivo, Injection, Western Blot, Expressing, Quantitation Assay, In Vitro
Related Articles
other:Article Title: ESCRTs regulate amyloid precursor protein sorting in multivesicular bodies and intracellular amyloid-β accumulation Article Snippet: Leupeptin and Incubation:Article Title: Impairment of chaperone-mediated autophagy leads to selective lysosomal degradation defects in the lysosomal storage disease cystinosis Article Snippet: Bone marrow was collected from femurs and tibia of mice and was used to prepare BMDMs, which were cultured in DMEM supplemented with 10% FBS and 20% L929-conditioned medium in the presence of antibiotics (Life Sciences). .. Starvation and recovery protocols For macroautophagy studies, two starvation protocols were used: Protocol 1 consisted of complete nutrient deprivation (amino acid/serum starvation), in which WT and Ctns −/− cells were washed briefly in HBSS (Gibco) and media-aspirated, and fresh HBSS was added again, followed by 45 min of incubation at 37°C, in the presence or absence of the lysosomal inhibitors bafilomycin A (LC laboratories, 100 nM), Activation Assay:Article Title: Anabolic SIRT4 Exerts Retrograde Control over TORC1 Signaling by Glutamine Sparing in the Mitochondria Article Snippet: For glutamine supplementation experiments, cells were kept in 2 mM glutamine supplemented in 5 mM glucose- or 25 mM glucose-containing DMEM (as indicated in the figures) for 1 h. For the GDH assay, the cells were cultured in 5 mM glucose-containing DMEM. .. For AMPK activation, 0.5 mM AICAR (Sigma, catalog no. A9978) was used as a high dose, and 0.03 mM was used as a low dose for 1 h. For AMPK inhibition, compound C (dorsomorphin; Sigma, catalog no. A5499) was used at a 20 μM dose for 1 h. For increasing anaplerotic flux, 10 mM dimethyl α-ketoglutarate (DMKG; Sigma, catalog no. 349631) was added to cells for 1 h. For Arf1 inhibition, 10 μM brefeldin A was added in low-glucose conditions for 1 h. For inhibition of autophagy flux, the cells were kept in either low (5 mM)- or high (25 mM)-glucose medium with or without 100 μM Inhibition:Article Title: Anabolic SIRT4 Exerts Retrograde Control over TORC1 Signaling by Glutamine Sparing in the Mitochondria Article Snippet: For glutamine supplementation experiments, cells were kept in 2 mM glutamine supplemented in 5 mM glucose- or 25 mM glucose-containing DMEM (as indicated in the figures) for 1 h. For the GDH assay, the cells were cultured in 5 mM glucose-containing DMEM. .. For AMPK activation, 0.5 mM AICAR (Sigma, catalog no. A9978) was used as a high dose, and 0.03 mM was used as a low dose for 1 h. For AMPK inhibition, compound C (dorsomorphin; Sigma, catalog no. A5499) was used at a 20 μM dose for 1 h. For increasing anaplerotic flux, 10 mM dimethyl α-ketoglutarate (DMKG; Sigma, catalog no. 349631) was added to cells for 1 h. For Arf1 inhibition, 10 μM brefeldin A was added in low-glucose conditions for 1 h. For inhibition of autophagy flux, the cells were kept in either low (5 mM)- or high (25 mM)-glucose medium with or without 100 μM Real-time Polymerase Chain Reaction:Article Title: Anabolic SIRT4 Exerts Retrograde Control over TORC1 Signaling by Glutamine Sparing in the Mitochondria Article Snippet: For glutamine supplementation experiments, cells were kept in 2 mM glutamine supplemented in 5 mM glucose- or 25 mM glucose-containing DMEM (as indicated in the figures) for 1 h. For the GDH assay, the cells were cultured in 5 mM glucose-containing DMEM. .. For AMPK activation, 0.5 mM AICAR (Sigma, catalog no. A9978) was used as a high dose, and 0.03 mM was used as a low dose for 1 h. For AMPK inhibition, compound C (dorsomorphin; Sigma, catalog no. A5499) was used at a 20 μM dose for 1 h. For increasing anaplerotic flux, 10 mM dimethyl α-ketoglutarate (DMKG; Sigma, catalog no. 349631) was added to cells for 1 h. For Arf1 inhibition, 10 μM brefeldin A was added in low-glucose conditions for 1 h. For inhibition of autophagy flux, the cells were kept in either low (5 mM)- or high (25 mM)-glucose medium with or without 100 μM Luciferase:Article Title: Anabolic SIRT4 Exerts Retrograde Control over TORC1 Signaling by Glutamine Sparing in the Mitochondria Article Snippet: For glutamine supplementation experiments, cells were kept in 2 mM glutamine supplemented in 5 mM glucose- or 25 mM glucose-containing DMEM (as indicated in the figures) for 1 h. For the GDH assay, the cells were cultured in 5 mM glucose-containing DMEM. .. For AMPK activation, 0.5 mM AICAR (Sigma, catalog no. A9978) was used as a high dose, and 0.03 mM was used as a low dose for 1 h. For AMPK inhibition, compound C (dorsomorphin; Sigma, catalog no. A5499) was used at a 20 μM dose for 1 h. For increasing anaplerotic flux, 10 mM dimethyl α-ketoglutarate (DMKG; Sigma, catalog no. 349631) was added to cells for 1 h. For Arf1 inhibition, 10 μM brefeldin A was added in low-glucose conditions for 1 h. For inhibition of autophagy flux, the cells were kept in either low (5 mM)- or high (25 mM)-glucose medium with or without 100 μM |